A controlled clinical exploratory study on genetic markers for peri-implantitis

Area of Science:

• Dental Implantology
• Periodontology
• Molecular Biology

Background:

• Peri-implantitis is a common complication of dental implants, characterized by inflammation and bone loss.
• Understanding the molecular mechanisms of bone resorption in peri-implantitis is crucial for diagnosis and treatment.
• Peri-implant crevicular fluid (PICF) contains biomarkers that may reflect the local inflammatory and bone remodeling status.

Purpose of the Study:

• To compare gene expression of bone resorption/remodeling markers in PICF from healthy subjects and those with peri-implantitis.
• To investigate the presence of specific biomarkers such as TRAP, DKK-1, OPG, CatK, and OC.

Main Methods:

• A cross-sectional study involving PICF sampling from 7 healthy subjects and 7 subjects with peri-implantitis.
• Quantitative polymerase chain reaction (qPCR) was used to analyze gene expression.
• Focus on biomarkers related to bone degradation and remodeling.

Main Results:

• Gene expression levels of bone resorption/remodeling markers were similar between healthy and peri-implantitis groups.
• Only one subject with peri-implantitis showed genetic markers for bone degradation, and this subject had rheumatoid arthritis.
• Six out of seven peri-implantitis patients did not exhibit detectable bone resorption markers.

Conclusions:

• Patients with clinical signs of peri-implantitis and bone loss may show similar gene expression profiles as healthy individuals.
• The absence of bone resorption markers in most peri-implantitis patients suggests bone degradation was not active at the time of PICF sampling.
• Further research is needed to understand the discrepancy between clinical signs and molecular markers of bone resorption.